Dr. Wong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-615-0063Fax+1 215-349-8144
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1999 - 2002
- Rutgers Robert Wood Johnson Medical SchoolClass of 1999
Certifications & Licensure
- PA State Medical License 2000 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer Start of enrollment: 2006 Aug 01
- Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer Start of enrollment: 2008 Jun 01
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
- Join now to see all
Publications & Presentations
PubMed
- Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience.Abhishek A Solanki, Kevin Zheng, Alicia N Skipworth, Lisa M Robin, Ryan F Leparski
Current Oncology. 2024-08-21 - Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured onF-DCFPyL PET/CT.Miles Hsu, Xinhe Shan, Rebecca Zhang, Eva Berlin, Arun Goel
Clinical Genitourinary Cancer. 2024-08-01 - 1 citationsValidation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer.John K Lin, Caleb M Hearn, Emily Getzen, Qi Long, David C Lee
European Urology Oncology. 2024-08-01
Grant Support
- Clinical And Social Implications Of COST Sharing For Cancer DrugsNational Cancer Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: